Adults aged 20 and older should have their cholesterol measured

American Journal of Medicine

Volumn 102, Issue 2 A, 1997, Pages 31-36

  Cleeman, James I ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

AGE; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING;

EID: 0030960979     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00465-8     Document Type: Article

References (32)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. National Cholesterol Education Program: Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994; 89:1329-1445.
3. Murray DM, Luepker RV, Pirie PL, et al. Systematic risk factor screening and education: a community-wide approach to prevention of coronary heart disease. Prev Med. 1986;15:661-672.
4. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 1383-1389.
5. Sacks FM, Pfeffer MA, Moye LA, et al, for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
6. Shepherd J, Cobbe SM, Ford I, et al, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
7. Gordon DJ. Cholesterol lowering reduces mortality: results of updated meta-analysis. (Abstr.) Circulation. 1996;94(suppl):I-579.
8. Gordon DJ. Cholesterol lowering and total mortality. In: Rifkind BM, ed. Lowering cholesterol in high-risk individuals and populations. New York: Marcel Dekker, 1995.
9. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA. 1990;264:3018-3024.
10. Klag MJ, Ford DE, Mead LA, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993;328:313-318.
11. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA. 1987;257:2176-2180.
12. Denke MA. Cholesterol-lowering diets: a review of the evidence. Arch Intern Med. 1995;155:17-26.
13. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. JAMA. 1993;269:3002-3008.
14. Federation of American Societies for Experimental Biology, Life Sciences Research Office. Third Report on Nutrition Monitoring in the United States. Vol I. US Government Printing Office, Washington, DC, 1995.
15. National Heart, Lung, and Blood Institute Cholesterol Awareness Surveys, 1995. National Heart, Lung, and Blood Institute. Bethesda, MD: Press Conference; December 4, 1995.
16. Elton PJ, Ryman A, Hammer M, Page F. Randomised controlled trial in northern England of the effect of a person knowing their own serum cholesterol concentration. J Epidemiol Community Health. 1994;48:22-25.
17. Expert Panel on Population Strategies for Blood Cholesterol Reduction. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program. Circulation. 1991;83:2154-2232.
18. Kuller LH. Magnitude of the problem. In: Proceedings of the National Heart, Lung, and Blood Institute symposium on rapid identification and treatment of acute myocardial infarction. September 1991. National Heart, Lung, and Blood Institute; NIH Publication No. 91-3035.
19. Kannel WB, Schatzkin A. Sudden death: lessons from subsets in population studies. J Am Coll Cardiol. 1985;5:141B-149B.
20. Rossouw JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med. 1990;323:1112-1119.
21. Wenger NK. Gender, coronary disease, and coronary bypass surgery. Ann Intern Med. 1990;112:557-558.
22. Sempos CT, Cleeman JI, Carroll MK, et al. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA. 1993;269:3009-3014.
23. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Br Med J. 1991;303:893-896.
24. Manolio TA, Pearson TA, Wenger NK, et al. Cholesterol and heart disease in older persons and women: review of an NHLBI workshop. Ann Epidemiol. 1992;2:161-176.
25. Morbidity and Mortality: NHLBI Chartbook on Cardiovascular, Lung, and Blood Diseases. National Heart, Lung, and Blood Institute, NIH; May 1996.
26. Rubin SM, Sidney S, Black DM, et al. High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med. 1990;113:916-920.
27. Corti M-C, Guralnik JM, Salive ME, et al. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA. 1995;274:539-544.
28. Pedersen TR, Kjekshus J, Pyorala K, et al. Effect of simvastatin on survival and coronary morbidity in coronary heart disease patients 65 or older. (Abstr.) Circulation. 1995;92(suppl I):I-672.
29. Kuller L, Borhani N, Furberg C, et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the cardiovascular health study. Am J Epidemiol. 1994;139:1164-1179.
30. Miettinen TA, Pedersen T, Pyorala K, et al. Cholesterol lowering with simvastatin reduced major coronary events, revascularization procedures and cardiovascular hospitalizations in women participating in the Scandinavian Simvastatin Survival Study (4S). (Abstr.) Circulation. 1996;94(suppl):I-12.
31. Lewis SJ, Mitchell JS, East C, et al. Women in CARE have earlier and greater response to pravastatin post myocardial infarction. Circulation. (Abstr.) 1996;94(suppl):I-12.
32. Havel RJ. Analysis of angiographic trial data in women. Drugs. 1994;47(suppl 2):11-15.